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XObjective: Ischemia–reperfusion injury after lung transplantation remains a major source of morbidity and
mortality. Adenosine receptors have been implicated in both pro- and anti-inflammatory roles in ischemia–reper-
fusion injury. This study tests the hypothesis that the adenosine A2B receptor exacerbates the proinflammatory
response to lung ischemia–reperfusion injury.
Methods: An in vivo left lung hilar clamp model of ischemia–reperfusion was used in wild-type C57BL6 and
adenosine A2B receptor knockout mice, and in chimeras created by bone marrow transplantation between wild-
type and adenosine A2B receptor knockout mice. Mice underwent sham surgery or lung ischemia–reperfusion
(1 hour ischemia and 2 hours reperfusion). At the end of reperfusion, lung function was assessed using an isolated
buffer-perfused lung system. Lung inflammation was assessed by measuring proinflammatory cytokine levels in
bronchoalveolar lavage fluid, and neutrophil infiltration was assessed via myeloperoxidase levels in lung tissue.
Results: Compared with wild-type mice, lungs of adenosine A2B receptor knockout mice were significantly pro-
tected after ischemia–reperfusion, as evidenced by significantly reduced pulmonary artery pressure, increased
lung compliance, decreased myeloperoxidase, and reduced proinflammatory cytokine levels (tumor necrosis fac-
tor-a; interleukin-6; keratinocyte chemoattractant; regulated on activation, normal T-cell expressed and secreted;
and monocyte chemotactic protein-1). Adenosine A2B receptor knockout/adenosine A2B receptor knockout
(donor/recipient) and wild-type/ adenosine A2B receptor knockout, but not adenosine A2B receptor knock-
out/wild-type, chimeras showed significantly improved lung function after ischemia–reperfusion.
Conclusions: These results suggest that the adenosine A2B receptor plays an important role in mediating lung
inflammation after ischemia–reperfusion by stimulating cytokine production and neutrophil chemotaxis. The
proinflammatory effects of adenosine A2B receptor seem to be derived by adenosine A2B receptor activation pri-
marily on resident pulmonary cells and not bone marrow-derived cells. Adenosine A2B receptor may provide
a therapeutic target for prevention of ischemia–reperfusion-related graft dysfunction in lung transplant recipients.
(J Thorac Cardiovasc Surg 2010;140:871-7)One of the most common causes of early morbidity and mor-
tality after lung transplantation is primary graft dysfunction,
which is a severe form of ischemia–reperfusion (IR) injury.1
IR injury has been reported to account for up to 30% of early
mortality after lung transplantation.2 Although exact mech-
anisms of IR-induced injury remain unclear, numerous stud-
ies have established that acute inflammation is a key feature
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The Journal of Thoracic and CaAdenosine levels are known to increase in tissues as
a result of inflammation, IR, hypoxia, and cellular stress.
Adenosine is typically thought of as a retaliatory, anti-
inflammatory response that exerts its effects via cell-
surface G-coupled protein receptors, of which 4 subtypes
have been identified: A1 receptor (A1R), A2A receptor
(A2AR), A2B receptor (A2BR), and A3 receptor (A3R). The
activation of adenosine receptors in different tissues has
been shown to exert both pro- and anti-inflammatory re-
sponses.3 The most recent adenosine receptor gene to be
identified is A2BR, which is expressed on a broad spectrum
of cells in multiple organs, including the nervous system, in-
testines, lung, and heart. In the lung, A2BRs are highly ex-
pressed on alveolar epithelial cells.4 Among adenosine
receptors, the A2BR has the lowest affinity for adenosine,
and unlike other adenosine receptors it requires high levels
of adenosine for activation that may not be reached under
some physiologic conditions.5 On the other hand, the
expression of the receptor is induced under stresses, such
as injury or oxidative stress, or by tumor necrosis factor
(TNF)-a.6 Some studies have suggested an anti-
inflammatory role for A2BR in lung injury,
7 whereas othersrdiovascular Surgery c Volume 140, Number 4 871
Abbreviations and Acronyms
A1R ¼ A1 receptor
A2AR ¼ A2A receptor
A2BR ¼ A2B receptor
A3R ¼ A3 receptor
A2BR
/ ¼ A2BR knockout
BAL ¼ bronchoalveolar lavage
KC ¼ keratinocyte chemoattractant
IL ¼ interleukin
IR ¼ ischemia–reperfusion
MPO ¼ myeloperoxidase
RANTES¼ regulated on activation, normal T-cell
expressed and secreted
TNF ¼ tumor necrosis factor
WT ¼ wild-type
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Xhave shown a proinflammatory role.8 These contradictory
results underline the complexity in defining the role of
A2BR in lung injury, because it could highly depend on
the exact injury conditions applied and the relative contribu-
tion of bone marrow-derived versus tissue-derived A2BR in
promoting inflammation. For instance, bone marrow cell-
derived A2BRs are clear protectors of inflammation,
9,10
whereas this might not apply to tissue-derived A2BR.
We previously showed that activation of A2AR in the lung
produces potent anti-inflammatory responses leading to im-
proved lung function after IR.11,12 The current study tested
the ability of the A2BR to mediate lung injury and
dysfunction after IR. A2BR knockout (A2BR
/) mice were
used to demonstrate the contribution of A2BR to lung IR
injury as measured by pulmonary function and cytokine/
chemokine production. Through the use of bone marrow
chimeras, the role of A2BR on bone marrow versus non-bone
marrow-derived cells in mediating IR injury was clarified.
MATERIAL AND METHODS
Animals and Study Design
This study used 8- to 12-week-old male C57BL/6 wild-type (WT) mice
(Jackson Laboratory, Bar Harbor, ME) and A2BR
/mice. The A2BR
/mice
have been backcrossed onto the C57BL/6 background and display a normal
phenotype. Their generation and characterization have been described.9
Groups of mice (n ¼ 5/group) underwent left lung IR or sham surgery
(left thoracotomy). Preliminary analysis revealed that lung function in
A2BR
/ mice does not differ from WT mice, and thus a sham group of
A2BR
/ mice was not included in our comparisons. Separate groups of
bone marrow chimeric mice were generated (n ¼ 5/group) that underwent
lung IR. This study conformed to the Guide for the Care and Use of Labo-
ratory Animals published by the National Institutes of Health (publication
No. 85-23, revised 1985) and was conducted under protocols approved by
the University of Virginia’s Institutional Animal Care and Use Committee.
In Vivo Model of Lung Ischemia–Reperfusion
An in vivo hilar clamp model of IR was used as previously described.13
Mice were anesthetized using inhalational isoflurane, intubated, and venti-872 The Journal of Thoracic and Cardiovascular Surglated at a rate of 120 strokes/min with room air (Harvard Apparatus Co, South
Natick, Mass). Stroke volume was set at 1 mL, and peak inspiratory pressure
was limited to less than 20 cmH2O. Heparin (20 U/kg) was injected via the
right external jugular vein to prevent thrombosis during ischemia. A left tho-
racotomy was performed in the third intercostal space. A 6-0 Prolene suture
was passed around the hilum using a curved 22-G gavage needle. Both ends
of the suture were then threaded through a 5-mm–long PE-50 tubing. Ische-
mia was initiated by pulling up on the suture and thus pressing the tube
against the hilum and occluding it. A small surgical clip was applied to the
suture at the end of the tube to maintain tension of the tube against the hilum.
The thoracotomy was then closed, and the mouse was extubated and returned
to its cage. Animals were kept warm by using a heat lamp. The average time
for this stage of the procedure was 15 minutes per mouse. After a 1-hour pe-
riod of ischemia, the mouse was reanesthetized and reintubated. Reperfusion
was achieved by cutting the suture and removing the clip and the tubing.
Again the thoracotomy was closed, and the mouse was extubated and re-
turned to its cage. The average time for this stage of the procedure was 5 min-
utes. The animals were subsequently reperfused for 2 hours before analysis.
To minimize pain and discomfort, an analgesic (buprenorphine, 0.2 mg/kg)
was administered to all animals at the beginning of surgical intervention.
Generation of Chimeric Mice
Bone marrow chimeras were produced using standard techniques as pre-
viously described.14 Briefly, donor mice (male, 24–26 g, age 8–10 weeks)
were anesthetized with Nembutal (0.02 mg/g) and euthanized by cervical
dislocation. Bone marrow from femurs was harvested under sterile condi-
tions, yielding approximately 50 million nucleated bone marrow cells
per mouse. The recipient mice (male, 22–25 g, age 6 weeks) were irradiated
with 2 doses of 6 Gy each, 4 hours apart. Immediately after irradiation the
mice were anesthetized using inhalational anesthesia and injected with 2 to
4 3 106 bone marrow cells via the tail vein. One control mouse did not
receive an injection and subsequently died to confirm the efficacy of
bone marrow depletion by irradiation. Transplanted mice were housed
in micro-isolator cages for 6 weeks before experimentation. The
following 4 different chimeras were produced (donor/recipient): WT/
WT, A2BR
//A2BR
/, WT/A2BR
/, and A2BR
//WT (n¼ 5/group).
Measurement of Pulmonary Function
At the end of the 2-hour reperfusion period, pulmonary function was
evaluated using an isolated, buffer-perfused mouse lung system (Hugo
Sachs Elektronik, March-Huggstetten, Germany) as previously described
by our laboratory.15 Briefly, mice were anesthetized using a mixture of ket-
amine and xylazine. A tracheostomy was performed, and animals were ven-
tilated with room air at 100 strokes/min and a tidal volume of 7 mL/g with
a positive end-expiratory pressure of 2 cm H2O. The animals were exsangui-
nated by transecting the inferior vena cava. The pulmonary artery was can-
nulated through the right ventricle, and the left ventricle was tube-vented
through a small incision at the apex of the heart. The lungs were then
perfused at a constant flow of 60 mL/g/min with Krebs–Henseleit buffer
containing 2% albumin, 0.1% glucose, and 0.3% N-2-hydroxyethylpiper-
azine-N-2 ethanesulfonic acid (335–340 mOsm/kg H2O). The perfusate
buffer and isolated lungs were maintained at 37C throughout the experi-
ment using a circulating water bath. Once properly perfused and ventilated,
the lungs were maintained on the system for a 5-minute equilibration period
before data were recorded for an additional 5 minutes. Hemodynamic and
pulmonary parameters were recorded using the PULMODYN data acquisi-
tion system (Hugo Sachs Elektronik).
Bronchoalveolar Lavage
After pulmonary function measurements, the right lung was occluded us-
ing a surgical clip. The left lung was lavaged with 0.4 mL of normal saline.
The bronchoalveolar lavage (BAL) fluid was then immediately centrifuged
at 4C (500g for 5 minutes), and the supernatant was stored at80C until
further analysis.ery c October 2010
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FIGURE 1. Pulmonary function after IR. Pulmonary artery pressure, pul-
monary compliance, and airway resistance were improved after IR in
A2BR
/ mice compared with WT mice. *P < .05 versus WT sham,
#P< .05 versus WT IR (n ¼ 5/group). A2BR/, A2BR knockout; IR, ische-
mia–reperfusion; WT, wild-type.
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XMeasurement of Myeloperoxidase
Myeloperoxidase (MPO) levels were measured in lung tissue using
a commercially available mouse MPO enzyme-linked immunosorbent assay
kit (Cell Sciences, Canton, Mass), and MPO levels were expressed as nano-
grams of MPO per micrograms of total lung protein. Lung tissue was
homogenized in cell lysis buffer (Bio-Rad Laboratories, Hercules, Calif).
Measurement of Cytokines and Chemokines
Cytokines/chemokines in BAL fluid were quantified using a Bio-Plex
Mouse Cytokine Multiplex Assay (Bio-Rad Laboratories) as previously
performed.16 The samples were analyzed as instructed with a Bioplex array
reader, which is a fluorescent-based flow cytometer using a bead-based mul-
tiplex technology, each of which is conjugated with a reactant specific for
a different target molecule.
Statistical Analysis
All data are presented as the mean  standard error of the mean. Data
were compared by 1-way analysis of variance, followed by Satterthwaite
t test for unpaired data, which provides an adjustment for unequal variance
between groups.The Journal of Thoracic and CaRESULTS
Pulmonary Function Is Improved After Ischemia–
Reperfusion in A2BR
/Mice
As expected, pulmonary function was significantly im-
paired in lungs of WT mice after IR (WT IR) compared
with WT sham mice (Figure 1). Pulmonary artery pressure
was significantly increased, and lung compliance was signif-
icantly decreased in WT IR mice. Airway resistance was also
higher in the WT IR mice but did not reach statistical signif-
icance. Compared with WT mice, pulmonary dysfunction
was improved in strain-, age-, and sex-matched A2BR
/
mice after IR, where the A2BR
/mice displayed significantly
reduced pulmonary artery pressure, improved pulmonary
compliance, and reduced airway resistance (Figure 1).A2BR Deficiency Attenuates Cytokine/Chemokine
Production After Ischemia–Reperfusion
The levels of TNF-a, interleukin (IL)-6, keratinocyte
chemoattractant (KC) (CXCL1), and regulated on activation,
normal T-cell expressed and secreted (RANTES) in BAL
fluid were significantly increased in WT IR mice compared
with sham (Figure 2). The A2BR
/mice showed significantly
reduced levels of TNF-a, IL-6, KC, and RANTES after IR
versus WT IR mice (Figure 2). MCP-1 level was also higher
in WT IR lungs and was reduced in A2BR
/ lungs, but this
did not reach statistical significance (Figure 2).Neutrophil Infiltration After Ischemia–Reperfusion
Is Attenuated in the Absence of A2BR
MPO is abundant in the azurophilic granules of polymor-
phonuclear neutrophils and was used as an indicator of neu-
trophil infiltration in lung tissue. As expected, MPO levels
were significantly increased in lungs of WT mice after IR
versus sham (Figure 3). MPO levels were significantly
decreased in A2BR
/ mice after IR compared with WT IR
(Figure 3).Proinflammatory Effects of A2BR Are Mediated by
A2BR on Resident Pulmonary Cells
Pulmonary function was measured after IR in 4 groups of
bone marrow chimeras. As expected, pulmonary artery pres-
sure was significantly decreased and pulmonary compliance
was significantly increased in A2BR
//A2BR
/ chimeras
compared with WT/WT chimeras (Figure 4). Significant
attenuation of lung dysfunction was also observed in the
WT/A2BR
/ chimeras, where these mice displayed re-
duced pulmonary artery pressure and increased pulmonary
compliance compared with WT/WT (Figure 4). No pro-
tection was observed in the A2BR
//WT chimeras, where
pulmonary artery pressure and compliance were similar to
that of WT/WT controls. Airway resistance was not sig-
nificantly different among the 4 groups of chimeras.rdiovascular Surgery c Volume 140, Number 4 873
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FIGURE 2. Expression of cytokines in BAL fluid after IR. Expression of TNF-a, IL-6, KC (CXCL1), RANTES, and MCP-1 were all significantly increased
in WT mice after IR versus sham. Cytokine levels in A2BR
/mice after IR were significantly attenuated compared with WT IR. *P< .05 versus WT sham,
#P< .05 versus WT IR (n ¼ 5/group). TNF, Tumor necrosis factor; IL, interleukin; KC, keratinocyte chemoattractant; IR, ischemia–reperfusion; WT, wild-
type; MCP, monocyte chemotactic protein; RANTES, regulated on activation, normal T-cell expressed and secreted; A2BR
/, A2BR knockout.
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XDISCUSSION
This study used an in vivo mouse model to show that A2BR
plays a proinflammatory role in lung IR injury. A2BR
/mice
were used to demonstrate that A2BR gene deletion attenuates
inflammatory responses in the lung after IR. Our data illus-
trate that pulmonary dysfunction is significantly attenuated
in A2BR
/mice compared with WT mice, as evidenced by
reduced pulmonary artery pressure and airway resistance
and improved pulmonary compliance. In addition, lung
inflammation after IR was significantly attenuated in
A2BR
/mice, as evidenced by reduced production of proin-
flammatory cytokines/chemokines and MPO levels.
Bone marrow chimeric mice were used in an effort
to identify key A2BR-expressing cellular subsets that
mediate proinflammatory responses after lung IR. In the
WT/A2BR
/ chimeras, only bone marrow-derived cells
(eg, leukocytes or macrophages) express A2BR.
4 In the
A2BR
//WT chimeras, only non-bone marrow-derived
cells (eg, smooth muscle cells, endothelial cells, and epithe-
lial cells) express A2BR.
4,9,17 Our results show that lungs of874 The Journal of Thoracic and Cardiovascular SurgWT/A2BR
/ but not A2BR
//WT chimeras were
significantly protected after IR, suggesting that A2BRs on
non-bone marrow-derived cells in the lung (ie, resident pul-
monary cells such as epithelial cells) play a predominant role
in mediating the inflammatory response after IR injury.
Compelling evidence has shown that lung IR injury is me-
diated by inflammatory responses.13,16,18 Studies have also
indicated that activated neutrophils are a primary mediator
of this inflammatory response.12,18,19 The results of the
MPO assay in the current study (that IR-induced MPO levels
are attenuated in the A2BR
/mice) are consistent with our
pulmonary function data, suggesting neutrophil chemotaxis
as a possible mechanism of the A2BR’s role in lung IR.
Our data suggest that another mechanism for A2BR-medi-
ated proinflammatory responses in lung IR is through the
modulation of cytokine/chemokine levels. The decrease in
expression of KC, which is a potent neutrophil chemoattrac-
tant, in the A2BR
/ mice suggests a proinflammatory role
consistent with our MPO results. Furthermore, KC is known
to be largely secreted by pulmonary epithelial cells, whichery c October 2010
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FIGURE 3. MPO levels in lung tissue were significantly elevated in WT
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FIGURE 4. Pulmonary function after IR in bone marrow chimeras. All
groups underwent lung IR. Pulmonary artery pressure and pulmonary com-
pliance were significantly improved in A2BR
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/ and WT/
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/ chimeras compared with WT/WT chimeras (donor/recipient).
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//WT (n ¼ 5/group).
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/, A2BR knockout; IR, ischemia–reperfusion; WT, wild-type.
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Xsupports the results of the bone marrow chimera experiment
(that the A2BR’s role in lung IR is mediated through resident
pulmonary cells). This suggests that it is possible that A2BR-
mediated inflammation after IR is primarily directed by
A2BR activation on lung epithelial cells. In addition, we ob-
served that IL-6 levels were attenuated in the A2BR
/mice
after IR. A prior study by Ryzhov and colleagues20 demon-
strated that A2BR exerts a proinflammatory response via
secretion of IL-6, which is consistent with our observations.
The role of A2BR in modulating inflammatory responses
to injury is complex and remains controversial. Studies
have shown both pro- and anti-inflammatory responses
for A2BR depending on the model and tissue used. A proin-
flammatory role of A2BR has been reflected in several stud-
ies.21-24 For example, it has been shown that stimulation of
A2BR exerts a proinflammatory role by stimulating IL-6
secretion and suppressing TNF-a production in mice.20 In
addition, Zhong and colleagues24 showed that A2BR activa-
tion in human bronchial epithelial cells increases IL-19
secretion, which subsequently stimulates TNF-a release by
monocytes. On the other hand, a number of studies have
demonstrated an anti-inflammatory role for A2BR in differ-
ent settings.7,9,25,26 For example, basal levels of some
proinflammatory cytokines, such as TNF-a, were found to
be increased in tissues of A2BR
/ mice,22 and this has
been interpreted as an anti-inflammatory role for A2BR. In
addition, a recent study by Schingnitz and colleagues27 dem-
onstrated a protective role of A2BR signaling in an
endotoxin-driven lung injury model that was dependent on
pulmonary A2BR signaling. These seemingly contradicting
findings of A2BR may be due to its various signaling partnersThe Journal of Thoracic and Cain different tissues and whether the signal in the system used
originates from bone marrow cells or from tissues. Further-
more, some studies have shown that A2BR may exist in
a multiprotein complex in the lung epithelia, and interactions
with these partners may explain the different effects.22,28
Endotoxin-induced inflammation is acute, involving a sharp
elevation of inflammatory signals and cytokines, which typ-
ically involves bone marrow-derived cells. This has proven
to be the case also with regard to the contribution of bone
marrow cell A2BR to acute inflammation, as we have previ-
ously shown.9 This is different from pulmonary tissue A2BR
signaling, which evokes a milder and likely localized inflam-
matory profile. Indeed, in our lung IR injury model, tissue-
derived rather than bone marrow-derived A2BR signals are
involved. Our study leads us to suggest a paradigm accord-
ing to which the response of A2BR to stress depends on
whether it is an acute, systemic stress that involves bonerdiovascular Surgery c Volume 140, Number 4 875
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Xmarrow cells or rather localized stress that involves tissue
signals. Continued investigations will be required to better
understand the pro- and anti-inflammatory roles of A2BR un-
der different settings.
Ventilator-induced injury could account for a significant
part of the effects observed in various in vivo lung IR
models. However, unlike many of these models in which
mice are maintained on ventilation throughout reperfusion,
we have reduced the total time of mechanical ventilation
to less than 20 minutes to minimize injury caused by venti-
lation. This was done by extubating the animal during both
the 1-hour ischemic and 2-hour reperfusion periods. The
minimal lung injury and well-preserved function observed
in our sham mice further support this point. Another limita-
tion of our model is the assessment of lung function with the
isolated, buffer-perfused lung system that includes both right
and left lungs. As such, total lung function is measured and
not just left lung function. However, this is a necessity of the
system to prevent unacceptable injury to the left lung as a re-
sult of ventilation. Despite this, we have clearly demon-
strated significantly impaired lung function after left hilar
clamp versus sham and are confident that the dysfunction
measured in our experiments is reflective of left lung injury.
An additional potential limitation of this study is that the
expression of other adenosine receptors (A1R, A2AR and
A3R) could have been abnormally affected in the A2BR
/
mice after IR. This is unlikely, however, because we previ-
ously showed that A2BR gene deletion does not significantly
affect the expression or activity of other adenosine receptor
subtypes, as evidenced by reverse transcriptase-polymerase
chain reaction.9 Thus, the observed effects in the A2BR
/
mice likely cannot be attributed to compensatory changes
in expression of other adenosine receptors. We acknowledge
that although the expression of any or all adenosine recep-
tors could change after lung IR, this would apply to both
WT and A2BR
/mice, which was not a focus of our study.
CONCLUSIONS
Pulmonary IR is a complex inflammatory response in-
volving many components. The role of A2BR in this process
remains the focus of ongoing investigations. The current
study demonstrates a proinflammatory role for A2BR in the
acute setting of lung IR injury, as evidenced by functional
parameters, cytokine/chemokine expression, and MPO
levels. Furthermore, the proinflammatory effects of A2BR
can be attributed to A2BR activation primarily on resident
pulmonary (non-bone marrow-derived) cells such as epithe-
lia. These data suggest that A2BR may provide an additional
therapeutic target for prevention or treatment of IR injury in
lung transplant recipients. Although previous studies sug-
gest that agonists for other adenosine receptors (A1R,
A2AR, or A3R) may be therapeutic in the setting of lung
IR injury,29,30 the present study highlights the importance
of maintaining high specificity for these agonists to876 The Journal of Thoracic and Cardiovascular Surgprevent the activation of A2BR. Because a large amount of
extracellular adenosine is known to be produced after IR,
it may be optimal to use a combination therapy composed
of an A1R, A2AR, or A3R agonist along with an A2BR
antagonist. Fortunately, because IR injury is rapidly
initiated upon reperfusion and primary graft dysfunction
usually occurs within 48 hours, the use of adenosine
receptor agonists or antagonists to prevent IR injury would
likely be required only during the initial 24 to 48 hours
after transplant.References
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Dr Brendan Stiles (New York, NY). Farshad, that was nicely
presented. It is a good continuation of the work your group has
done. I am a bit curious why you didn’t use a sham experiment
on the knockout mice. Or did you do that?
Dr Anvari. Our preliminary studies on these knockout mice
showed that they are comparable to our WT mice in terms of pul-
monary function, and we saw similar measurements as the WT
mice. So we did not include 2 sham groups in these experiments.
Dr Stiles. So the baseline levels of cytokine expression, things
like that, are no different between the knockout and the sham?
Dr Anvari. The baseline levels were similar for function. As far
as cytokines, previous studies have shown that the baseline levels
of some of the cytokines, including TNF-a and IL-6 are elevated
in the knockout mice. So we did not repeat those experiments.
Dr Stiles. I am just concerned that you are knocking out a proin-
flammatory gene and then you are showing that there is a decrease
in cytokine induction after IR, which you attribute to the treatment.
Some of those things are downstream of the proinflammatory path-
way that has been knocked out. I am concerned that what you are
showing is more just a function of knocking that out rather than ac-
tual protection from IR. Do you think there is a way to tease that
out?The Journal of Thoracic and CaDr Anvari. This is an interesting question. The limitation with
knockouts, as you mentioned, is that the observed effects may be
the result of the creation of the knockout itself. We do know that
the expression of other adenosine receptors are unchanged in these
knockouts. I would look at this as a first step. We recently acquired
agonists and antagonists for this receptor, and I think that will be the
next step to validate these results. Our preliminary results look
promising.
Dr Stiles. That is great. What is the delivery method of those, the
agonists and antagonists?
Dr Anvari. Intravenous injections via the external jugular.
Dr Frank Sellke (Providence, RI). I have a technical question.
You used a t test for your statistical analysis, yet you had multiple
groups. Shouldn’t you use a multiple comparison test rather than a t
test?
Dr Anvari. We performed an analysis of variance (ANOVA)
followed by a t test for unpaired data.
Dr Sellke.Yes, but if you have multiple groups, you have to take
the multiple comparisons into consideration, not just an ANOVA.
You have to do a post hoc analysis with multiple comparisons like
a Bonferroni correction or one of these tests into play.
Dr Anvari. Correct. We did an ANOVA in conjunction with
a Tukey’s test. We also performed additional analyses by looking
at specific groups comparing 2 at a time using a t test.
Dr Sellke. So you are not really doing a Bonferroni correction if
you are doing just a t test.
Dr Anvari. No. ANOVA in conjunction with Tukey’s test. The
t test was used for additional analysis.
Dr Michael Jessen (Dallas, Tex). I enjoyed your study a lot.
That is good work. The biggest area in cardiothoracic surgery I
think where we see IR injury, as you pointed out, is in lung trans-
plantation, but it is a tough thing to model. In some ways your
model deviates from it. There is no denervation, no hypothermia,
no preservation solution, and no immunosuppression on board.
How confident are you that your findings will be maintained in a set-
ting that is more clinically relevant to lung transplantation?
Dr Anvari. Those are all very relevant issues. We adopted this
model as a first step in the process of better understanding the role
of this receptor in pulmonary IR. We chose a mouse model because
we had the benefit of the knockouts, and this provides a foundation.
We need to continue this work by using drugs in this model, and if
that confirms the results we are seeing, then we can take that to
a bigger animal and use a more clinically relevant model. But I
think this is an important first step in establishing that.
This in vivo model is, of course, as you mentioned, a warm is-
chemia model and doesn’t take into account all the factors you men-
tioned, but in the mouse is the best model short of actual
transplantation, which has recently been done. But, as you can
imagine, it is technically challenging and not easily reproducible.
Dr Glen Van Arsdell (Toronto, Ontario, Canada). Your group
has been working with adenosine receptors for some time. The pro-
gram also does lung transplantation. Have you taken human tissue
to see whether there is a difference in expression and correlated that
with IR that you see clinically?
Dr Anvari. We have not used any human tissue in our experi-
ments so far.
Dr Van Arsdell. Is that coming down the line?
Dr Anvari. Hopefully, in the near future.rdiovascular Surgery c Volume 140, Number 4 877
